Harender Kumar | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr. Harender Kumar | Neuroscience | Best Researcher Award 🏆

Research Scholar at Panjab University Chandigarh, India.

Harender Kumar, a Research Scholar at Panjab University, Chandigarh, specializes in behavioral neuroscience. His work primarily focuses on investigating the relationship between diet, gut health, and stress resilience using zebrafish as a model organism. Kumar has published three notable journal articles in SCI/Scopus-indexed journals, with impactful contributions to neuroscience and chemistry. His research demonstrates a promising ability to bridge fundamental science with potential real-world applications.

Profile

Scopus

Education 🎓:

Harender Kumar is pursuing his Ph.D. at Panjab University, Chandigarh, focusing on behavioral neuroscience. His academic journey reflects his dedication to understanding the complex interplay between biological systems and mental health. Harender’s educational background has provided a strong foundation in neuroscience, biology, and chemistry, enabling him to engage in cutting-edge research. At Panjab University, he has honed his expertise in experimental design, data analysis, and interdisciplinary collaboration, contributing significantly to his academic and professional growth. Through his education, Harender has developed a keen interest in the gut-brain axis, stress mechanisms, and the therapeutic potential of dietary interventions, preparing him for a promising career in research and innovation.

Work Experience 💼:

Harender Kumar has significant experience in behavioral neuroscience research, with a focus on gut-brain interactions and stress resilience. As a Research Scholar at Panjab University, he has conducted innovative studies using zebrafish models, exploring how dietary components influence mental health. Harender has collaborated with experts in chemistry to address diverse scientific challenges, such as detecting chemical agents and understanding synaptic remodeling. His hands-on expertise includes experimental planning, animal model studies, and data interpretation, which have resulted in publications in SCI/Scopus-indexed journals. Harender’s multidisciplinary experience reflects his ability to navigate complex scientific questions and contribute meaningfully to neuroscience and beyond.

Awards and Honors

Though specific awards and honors are not mentioned in the profile, Harender Kumar’s accomplishments in publishing high-quality research in reputable journals demonstrate academic recognition. His work has contributed to advancing behavioral neuroscience and interdisciplinary science. Securing awards such as research grants, best paper accolades, or conference presentations would further highlight his achievements and scholarly impact.

Research Interests:

Harender Kumar’s research centers on behavioral neuroscience, with an emphasis on understanding the gut-brain axis and its role in stress resilience. Using zebrafish as a model organism, he investigates the link between dietary factors and mental well-being, providing insights into potential therapeutic strategies. His multidisciplinary work integrates neuroscience, physiology, and chemistry, addressing critical issues such as synaptic remodeling and the stress-resilient effects of dietary interventions. Harender’s innovative approach has contributed to a deeper understanding of mental health challenges and opened avenues for novel dietary strategies to enhance emotional resilience.

📚 Publications 

Stress-resilient Effect of Spirulina platensis on Zebrafish Chronic Unpredictable Stress Model

Authors: Kumar, H., Kaur, K., Kaur, R.

Journal: Physiology & Behavior

Year: 2024

Citations: 0

Role of Spirulina in Structural Remodeling of Synapse in Telencephalon of Chronic Unpredictable Stress Model of Zebrafish

Authors: Kumar, H., Garg, V., Kaur, K., Kaur, R.

Journal: Annals of Neurosciences

Year: 2023

Citations: 0

Synthesis of a Trinuclear Zinc(II) Cluster Composed of [4.4.3.01,5]Tridecane Cages: A Rapid Detection and Degradation Probe for the Chemical Warfare Agent Simulant Diethyl Cyanophosphonate in Protein-rich Food Products

Authors: Thakur, S., Rohilla, J., Kumar, K., Kumar, H., Singh, R., Kaur, V., Kamboj, R.

Journal: Analyst

Year: 2023

Citations: 4

Conclusion 

Harender Kumar exhibits strong potential as a researcher in behavioral neuroscience, with impactful publications and an innovative focus on the gut-brain axis. While his current portfolio demonstrates high-quality research and interdisciplinary collaboration, there is room to enhance his profile by securing funded projects, expanding his professional engagement, and increasing the impact of his work through broader dissemination and applications. Overall, Harender is a commendable candidate for the Best Researcher Award, particularly for early-career recognition.

 

 

Luisa Pozzo | Neuroscience | Best Paper Award

Posted on by sciencefather

Dr. Luisa Pozzo | Neuroscience | Best Paper Award   🏆

Researcher at IBBA-CNR, Italy

Dr. Luisa Pozzo is a Researcher at the Institute of Agricultural Biology and Biotechnology of the National Research Council (CNR-IBBA) since 2011. She holds a degree in Veterinary Medicine from the University of Turin (2007) and a PhD in Veterinary Sciences (2011) from the same university. Dr. Pozzo also earned a Master’s degree in Food Science from the University of Pisa (2013). Her research focuses on the bio-functional characterization of food products, particularly their role in managing inflammation and oxidative stress in chronic degenerative diseases like diabetes and cardiovascular issues. She has worked internationally in France, Poland, and Spain and currently holds a teaching position at the University of Pisa. With an H-index of 17 and over 663 citations, Dr. Pozzo has made significant contributions to the fields of food science, nutraceuticals, and health research.

Profile

SCOPUS

ORCID

Education 🎓:

Dr. Luisa Pozzo completed her education with a strong focus on veterinary medicine and food science. She graduated in 2007 with a degree in Veterinary Medicine from the University of Turin. Following this, she pursued advanced studies and earned her PhD in Veterinary Sciences (XXIII cycle) from the same university in 2011. Further expanding her expertise, she obtained a 2nd level Master’s degree in “Food Science: quality, safety and human nutrition” from the University of Pisa in 2013. Dr. Pozzo also gained international experience during her PhD training at the Mycotoxicology Unit of the ENVT in France in 2010. This educational background has provided her with a robust foundation in both veterinary science and food-related research, fueling her work in areas like food bio-functionality and chronic disease prevention.

Work Experience 💼:

Dr. Luisa Pozzo has extensive research and teaching experience in the fields of veterinary medicine, food science, and nutrition. Since 2011, she has been a Researcher at the Institute of Agricultural Biology and Biotechnology of the National Research Council (CNR-IBBA), where she focuses on the bio-functional properties of food products in relation to chronic diseases. Her international experience includes a PhD training at the Mycotoxicology Unit at ENVT in France (2010), and research roles as a Host Researcher at the Institute of Animal Reproduction and Food Research in Poland (2015) and IATA CSIC in Spain (2018). Since 2016, Dr. Pozzo has been a university lecturer at the University of Pisa, teaching Applied Nutraceuticals in the Human Nutrition Sciences program. Additionally, she has served as a Section Editor for the Polish Journal of Food and Nutrition Sciences since 2019 and has been a technical-scientific expert for the Italian Ministry of Economic Development. Her work has contributed to advancing the understanding of food’s role in health, with particular emphasis on antimicrobial and prebiotic effects.

Skills 🔍

Dr. Luisa Pozzo possesses a diverse skill set spanning veterinary medicine, food science, and nutrition research. Her expertise includes the bio-functional characterization of food products, with a focus on their role in preventing inflammation and oxidative stress associated with chronic degenerative diseases such as diabetes, cardiovascular diseases, and neurodegenerative disorders. She is skilled in using in vivo models (mice and rats) for testing the interactions between food products and drug metabolism. Additionally, Dr. Pozzo has expertise in antimicrobial and prebiotic effects of food products and bioactive compounds through in vitro testing. Her strong academic background and international research experience have equipped her with advanced skills in scientific communication, project evaluation, and academic mentorship, particularly in the fields of applied nutraceuticals and human nutrition.

Awards and Honors 🏆

Dr. Luisa Pozzo has received notable recognition for her contributions to the fields of food science and nutrition. In addition to her academic achievements, she has been acknowledged for her role as a Section Editor for the Polish Journal of Food and Nutrition Sciences (PJFNS) since 2019, where she contributes to advancing nutritional research. Her expertise has also been sought by the Italian Ministry of Economic Development (MiSE), where she has served as a technical-scientific expert for the evaluation of research projects under the Fund for Sustainable Growth. Furthermore, Dr. Pozzo’s dedication to international academic collaboration was recognized through a Staff Mobility for Teaching Assignments (STA) under the Erasmus+ Mobility Program in 2022, further cementing her standing in the global scientific community.

Research Interests:

Dr. Luisa Pozzo’s research interests center around the bio-functional characterization of food products, focusing on their protective roles in combating inflammation and oxidative stress associated with chronic degenerative diseases, including diabetes, cardiovascular diseases, neurodegenerative diseases, and chronic respiratory conditions. She is particularly interested in understanding the interactions between food products, bioactive compounds, and drug metabolism, using in vivo models (mice and rats) to explore these effects. Additionally, Dr. Pozzo investigates the antimicrobial and prebiotic properties of food products, seeking to identify potential health benefits and applications in disease prevention and management. Her research aims to contribute to the development of nutraceutical strategies for improving public health.

📚 Publications 

  • Title: Probing the Alterations in Mice Cecal Content Due to High-Fat Diet
    • Authors: Trouki, C., Campanella, B., Onor, M., Longo, V., Bramanti, E.
    • Journal: Food Chemistry
    • Year: 2024
    • Volume/Issue: 455, 139856
    • Citations: 0
  • Title: Assessment of the Antioxidant and Hypolipidemic Properties of Salicornia europaea for the Prevention of TAFLD in Rats
    • Authors: Souid, A., Giambastiani, L., Castagna, A., Pozzo, L., Vornoli, A.
    • Journal: Antioxidants
    • Year: 2024
    • Volume/Issue: 13(5), 596
    • Citations: 3
  • Title: Characterization and Stability Evaluation of Egyptian Propolis Extract Nano-Capsules and Their Application
    • Authors: Amin, A.A., Mahmoud, K.F., Salama, M.F., Seliem, E.I., Ibrahim, M.A.
    • Journal: Scientific Reports
    • Year: 2023
    • Volume/Issue: 13(1), 16065
    • Citations: 2
  • Title: Chlamydomonas agloeformis from the Ecuadorian Highlands: Nutrients and Bioactive Compounds Profiling and In Vitro Antioxidant Activity
    • Authors: Grande, T., Vornoli, A., Lubrano, V., Echeverria, M.C., Pozzo, L.
    • Journal: Foods
    • Year: 2023
    • Volume/Issue: 12(17), 3147
    • Citations: 4
  • Title: Characterization of Antioxidant and Antimicrobial Activity and Phenolic Compound Profile of Extracts from Seeds of Different Vitis Species
    • Authors: Pozzo, L., Grande, T., Raffaelli, A., Amarowicz, R., Karamać, M.
    • Journal: Molecules
    • Year: 2023
    • Volume/Issue: 28(13), 4924
    • Citations: 9
  • Title: In Vitro Characterization of Antioxidant, Antibacterial, and Antimutagenic Activities of the Green Microalga Ettlia pseudoalveolaris
    • Authors: Vornoli, A., Grande, T., Lubrano, V., Pozzo, L., Echeverria, C.
    • Journal: Antioxidants
    • Year: 2023
    • Volume/Issue: 12(6), 1308
    • Citations: 5

Conclusion 

Given Dr. Luisa Pozzo’s extensive research on the bio-functional roles of food in chronic disease prevention, her strong academic credentials, and her contributions to the field of nutraceuticals, she is a highly suitable candidate for the Research for Best Paper Award. Her research not only enhances our understanding of food’s potential to improve health but also paves the way for innovative solutions to combat chronic diseases.

 

 

Sandeep Agnihotri | Cognitive Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr. Sandeep Agnihotri | Cognitive Neuroscience | Best Researcher Award🏆

Research Associate at Guangdong Institute of Intelligence Science and Technology, China
🎓

Raziel Alejandro Arias Sánchez is a highly accomplished researcher with expertise in biotechnology and health sciences, particularly in clinical and experimental pathophysiology. His work focuses on chronic degenerative diseases, including neurodegeneration and diabetes mellitus. At only 27 years old, he has earned academic distinctions and contributed to impactful scientific literature as the primary author of articles and book chapters in reputable journals like Molecules. Raziel has actively participated in conferences, presented research, and contributed to the scientific community through collaborative projects and dissemination activities.

 

Profile 

Education 🎓:

Sandeep Kumar Agnihotri holds a Ph.D. in Cellular and Molecular Biology from Jawaharlal Nehru University (JNU), New Delhi, India, awarded in 2013. His doctoral research focused on the regulation of cadmium-mediated stress responses in mammalian systems. Prior to this, he earned an M.Sc. in Biotechnology from the University of Allahabad in 2006 and a B.Sc. in Life Sciences from Bundelkhand University, Jhansi, in 2000. He has consistently demonstrated academic excellence, securing full scholarships and top honors throughout his academic journey.

 

Work Experience 💼:

With over 15 years of extensive experience, Sandeep is currently a Research Associate at the Guangdong Institute of Intelligence Science and Technology (GDIIST) in China. He collaborates with Suiren Medical Technology to develop diagnostic tools for neurological disorders using EEG, fNIR, and AI data technology. Previously, he worked as a Senior Research Officer at Suiren Medical Technology and as a Postdoctoral Researcher at the Institute of Neuroscience (CEBSIT), Chinese Academy of Sciences, Shanghai. His work includes investigating cancer-associated fibroblasts in retinoblastoma and exploring the metabolic effects of neural stem cells.

🧬 Skills

Sandeep possesses a diverse skill set, including advanced cell biology techniques (3D culture, stem cell isolation, microscopy), molecular biology (CRISPR/Cas9 gene editing, RNAseq analysis), biochemical techniques (enzyme assays, proteomics), and neurobiological tools (stereotaxic injections, neuronal structure analysis). He is proficient in software like MATLAB, Python, R, ImageJ, FlowJo, and RNAseq tools for data analysis. He is also skilled in conducting behavioral studies on mice and applying AI-driven methods for Alzheimer’s diagnosis.

Awards and Honors🏆

Sandeep has received numerous accolades, including scholarships for his Ph.D. and M.Sc. programs, and the prestigious Meritorious Students Award from the University Grants Commission (UGC) in India. His Ph.D. at JNU, ranked among the top universities globally, further underscores his academic prowess.

📚 Teaching Experience

As part of his commitment to knowledge sharing, Sandeep has mentored several researchers and students throughout his career. His expertise in cellular biology, proteomics, and neurobiology has been shared via workshops and practical training sessions, including those on mass spectrometry and advanced proteomics at JNU.

 

📜 Memberships and Conferences

Sandeep actively participates in international conferences, where he has delivered presentations on topics ranging from neurogenesis to mitochondrial dynamics in cadmium toxicity. He has also been associated with collaborative projects, workshops, and training programs in proteomics and molecular biology.

 

Research Focus 🔬:

Sandeep’s research primarily revolves around neurological disorders, with a focus on understanding metabolic pathways in neurogenesis and the impact of neural stem cells on diseases like Parkinson’s and Alzheimer’s. His work also extends to cancer biology, where he has studied tumorigenesis mechanisms in retinoblastoma. He integrates AI tools for diagnosis and cognitive analysis, blending neuroscience with cutting-edge technology.

Conclusion 

Sandeep Kumar Agnihotri is a strong contender for the Best Researcher Award due to his diverse and impactful contributions to neuroscience, oncology, and environmental toxicology. His interdisciplinary approach, innovative research, and commitment to solving real-world problems make him a deserving candidate. With focused efforts on global collaborations, impactful publications, and translational research, he could further solidify his position as a leading figure in the scientific community.

 

📚 Publications

  • “Investigating the Effects of Transcranial Alternating Current Stimulation on Cortical Oscillations and Network Dynamics”
    • Year: 2024
    • Journal: Brain Sciences
  • “Loss of PTEN-Induced Kinase 1 Regulates Oncogenic Ras-Driven Tumor Growth By Inhibiting Mitochondrial Fission”
    • Year: 2022
    • Journal: Frontiers in Oncology
  • “PINK1 deficiency is associated with increased deficits of adult hippocampal neurogenesis and lowers the threshold for stress-induced depression in mice”
    • Year: 2019
    • Journal: Behavioural Brain Research
  • “Mechanistic Effect of Heavy Metals in Neurological Disorder and Brain Cancer”
    • Year: 2019
    • Journal: Networking of Mutagens in Environmental Toxicology (Book Chapter)
  • “Lack of PINK1 alters glia innate immune responses and enhances inflammation-induced, nitric oxide-mediated neuron death”
    • Year: 2018
    • Journal: Scientific Reports
  • “Loss of PINK1 leads to metabolic deficits in adult neural stem cells and impedes differentiation of newborn neurons in the mouse hippocampus”
    • Year: 2017
    • Journal: Not specified
  • “Cadmium Toxicity Showing Organ Specific Signature of Responsiveness”
    • Year: 2017
    • Journal: Perspectives in Environmental Toxicology (Book Chapter)
  • “Brain most susceptible to cadmium induced oxidative stress in mice”
    • Year: 2015
    • Journal: Not specified

 

 

 

 

Ioannis Charalampopoulos | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof. Ioannis Charalampopoulos
| Neuroscience | Best Researcher Award 🏆

Professor of Pharmacology at Medical School, University of Crete,Greece🎓

Dr. Ioannis Charalampopoulos is a distinguished Professor of Pharmacology at the University of Crete’s Medical School and a Group Leader at the Institute of Molecular Biology and Biotechnology (IMBB), Foundation of Research and Technology, Hellas (FORTH). With a focus on neuropharmacology and molecular biology, his research has contributed significantly to the study of neurodegenerative diseases, brain development, and regeneration. He has an extensive academic and research career spanning over two decades, with notable achievements in the development of novel therapeutic strategies for Alzheimer’s and spinal cord injury.

 

Professional Profile 

Education 🎓:

  • 2021-present: Director of the Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, Medical School, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden
  • 2001-2005: PhD in Pharmacology, Medical School, University of Crete
  • 1998-2000: Master of Science in Neurosciences, Medical School, University of Crete
  • 1990-1996: BSc, Department of Biology, University of Patras

Work Experience 💼:

  • 2023-present: Professor of Pharmacology, Medical School, University of Crete
  • 2018-present: Researcher/Group Leader, Institute of Molecular Biology and Biotechnology (IMBB), FORTH
  • 2021-present: Director, Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden

Skills 🔍

Dr. Charalampopoulos is highly skilled in neuropharmacology, molecular biology techniques, and neurodegenerative disease research. His expertise includes:

  • Neurotrophin receptor structure-function analysis
  • Development of therapeutic ligands for brain regeneration
  • Neurogenesis and neuroprotection strategies
  • Animal models of Alzheimer’s disease and spinal cord injury
  • Human iPSC-derived neural platforms for disease modeling
  • Collaborative research in neuroscience and pharmacology

Awards and Honors 🏆

Dr. Charalampopoulos has received multiple recognitions throughout his career, including prestigious grants for his innovative work in neuroscience and neurodegenerative disease treatment:

  • HORIZON-EIC-2022 European Commission Grant: Coordinating a project on soft-robot-assisted therapeutic delivery for neurological disorders (budget: 2.9 million euros).
  • National Flagship Project: Funding for the elucidation of the genetic basis of Alzheimer’s and Parkinson’s diseases (budget: 610,000 euros).
  • Numerous research accolades, with over 80 publications in peer-reviewed journals (h-index: 35, citations >3000).

🤝 Memberships:

Dr. Charalampopoulos is a member of several prestigious scientific organizations, including:

  • International Society for Neuroscience
  • European Society of Neurochemistry
  • Society for Neuroscience (SfN)
  • Greek Society for Pharmacology

Teaching Experience 👩‍🏫:

Dr. Charalampopoulos has been actively involved in educating future generations of neuroscientists, particularly through his role as the Director of the Graduate Program in Neurosciences at the University of Crete. His teaching experience includes:

  • Undergraduate and postgraduate courses in pharmacology, neuropharmacology, and molecular biology.
  • Mentoring and supervising PhD students and postdoctoral researchers in pharmacology and neuroscience.
  • Developing innovative teaching methods, including the use of human stem cell models in neuroscience research.

Research Focus 🔬:

Dr. Charalampopoulos’ research interests revolve around the molecular mechanisms by which growth factors and their receptors regulate the regenerative capacity of the nervous system. Key areas include:

  • Neurotrophins: Their role in brain development, neurogenesis, neuronal survival, and repair during aging.
  • Neurodegenerative Diseases: Investigating novel therapeutic strategies for Alzheimer’s disease, Parkinson’s disease, and spinal cord injury.
  • Ligand Development: Creating novel ligands targeting neurotrophin receptors to enhance regenerative and neuroprotective effects.
  • Stem Cell Models: Using human induced pluripotent stem cell-derived platforms to test therapeutics for neurodegenerative diseases.
    His ultimate goal is to decipher the signaling mechanisms underlying neurodegeneration and regeneration, leading to the development of novel drugs for brain repair.
Conclusion 

Dr. Ioannis Charalampopoulos is undoubtedly a top contender for the Best Researcher Award. His exceptional contributions to neuroscience, his innovative approaches in neuropharmacology, and his ability to secure substantial research funding demonstrate that he is not only an accomplished researcher but also a transformative figure in the field of neurodegenerative diseases. His strengths lie in the originality of his work, leadership in research initiatives, and mentorship in education. With slight improvements in public outreach, collaborative networks, and clinical translation, he can further elevate his already remarkable career. Therefore, Dr. Charalampopoulos is a highly deserving nominee for the Best Researcher Award, given his outstanding scientific contributions, leadership, and lasting impact on the field of neuroscience.

📚 Publilcation

  • “Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer’s disease”
    • Year: 2024
    • Journal: Frontiers in Cellular Neuroscience
    • Type: Review
    • DOI: 10.3389/fncel.2024.1422130
  • “Editorial: Steroid receptors in neuron and glia”
    • Year: 2024
    • Journal: Frontiers in Endocrinology
    • Type: Editorial
    • DOI: 10.3389/fendo.2024.1472908
  • “Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease”
    • Year: 2024
    • Journal: Stem Cell Research & Therapy
    • Type: Journal Article
    • DOI: 10.1186/s13287-024-03818-w
  • “Cover Image, Volume 72, Issue 4”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24399
  • “Dynamics of myelin deficits in the 5xFAD mouse model for Alzheimer’s disease and the protective role of BDNF”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24505
  • “Multimodal beneficial effects of BNN27, a Nerve Growth Factor synthetic mimetic, in the 5xFAD mouse model of Alzheimer’s Disease”
    • Year: 2024
    • Type: Preprint
    • DOI: 10.21203/rs.3.rs-3886007/v1
  • “Development of Pleiotropic TrkB and 5-HT<sub>4</sub> Receptor Ligands as Neuroprotective Agents”
    • Year: 2024
    • Journal: Molecules
    • Type: Journal Article
    • DOI: 10.3390/molecules29020515
  • “Butanolides and Butenolides from a Marine-Derived Streptomyces sp. Exert Neuroprotective Activity through Activation of the TrkB Neurotrophin Receptor”
    • Year: 2023
    • Journal: Marine Drugs
    • Type: Journal Article
    • DOI: 10.3390/md21090465
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor, Regulating Neuronal Survival in a Cell Context-Dependent Manner”
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
    • Type: Journal Article
    • DOI: 10.3390/ijms241411683
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor Promoting Cell Death in Mouse and Human Neuronal Cells”
    • Year: 2023
    • Type: Preprint
    • DOI: 10.20944/preprints202306.1633.v1

Prof Dr Ryszard Pluta | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof Dr Ryszard Pluta | Neuroscience | Best Researcher Award

MD.,PhD at  Medical University of Lublin , Poland

Dr. Ryszard Pluta is a distinguished neurologist and neuroscientist, with a medical degree from the Medical Academy in Lublin (1977) and a Ph.D. from the Polish Academy of Sciences (1983). He has served as a Professor at the Mossakowski Medical Research Institute and held prestigious postdoctoral fellowships at the NIH and NYS Institute for Basic Research. A recognized expert in brain ischemia and Alzheimer’s disease, Dr. Pluta has published extensively, including multiple influential books on the subject. He is a recipient of numerous awards and is an active member of several professional societies. His significant contributions to understanding the links between ischemia and Alzheimer’s have established him as a leading figure in neuropathology.

Profile:

Scopus 

Education 🎓

Ryszard Pluta earned his medical degree from the Medical Academy in Lublin (1971-1977) and attended Humboldt University in Berlin (1975) and the University of Cologne (1976). He completed his Ph.D. at the Polish Academy of Sciences in Warsaw (1983). He became an Associated Professor in 1992 and a full Professor in 2004 at the Mossakowski Medical Research Institute, Polish Academy of Sciences.

Work Experience 💼

Dr. Pluta has held prestigious positions, including postdoctoral fellowships at the NIH in Bethesda, USA (1986-1988), and the NYS Institute for Basic Research in New York (1988-1989). He has been a Visiting Professor at several renowned institutions, including the Max-Planck Institute for Neurological Research and Charles University in Prague.

Skills 🧠

With extensive expertise in neuropathology and neurochemistry, Dr. Pluta specializes in brain ischemia and Alzheimer’s disease research. His skills encompass project management, collaboration with international research teams, and contributions to clinical studies in the field of neuroscience.

Awards and Honors 🏆

Dr. Pluta has received numerous accolades, including recognition from the Polish Association of Neuropathologists (1980, 1986) and the Polish Academy of Sciences (1982, 1989, 1992). He was also honored by the International Brain Research Organization (1997) and the Alzheimer’s Association in Chicago (1998).

Membership 🤝

He is an active member of various professional organizations, including the Polish Association of Neuropathologists and the International Society of Neuropathology. Dr. Pluta is recognized among the World’s Top 2% scientists by Stanford University.

Teaching Experience 📚

Dr. Pluta has contributed to the academic community through teaching positions at various universities, where he has shared his knowledge and expertise in neuropathology and neuroscience with students and researchers.

Research Focus 🔬

His research focuses on brain ischemia, its relationship with Alzheimer’s disease, and associated neuropathological changes. He has made significant contributions, such as the documentation of identical changes in ischemic brains and those affected by Alzheimer’s, and the exploration of potential therapeutic approaches involving β-amyloid peptide.

 

Publications:

  • Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer’s Disease with Survival up to 2 Years
    • Year: 2024
    • Journal: Journal of Alzheimer’s Disease
  • Trans- and Cis-Phosphorylated Tau Protein: New Pieces of the Puzzle in the Development of Neurofibrillary Tangles in Post-Ischemic Brain Neurodegeneration of the Alzheimer’s Disease-like Type
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • A Look at the Etiology of Alzheimer’s Disease based on the Brain Ischemia Model
    • Year: 2024
    • Journal: Current Alzheimer Research
  • Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer’s Disease with 2-Year Survival
    • Year: 2024
    • Journal: Journal of Alzheimer’s Disease
  • Ischemia-Reperfusion Programming of Alzheimer’s Disease-Related Genes—A New Perspective on Brain Neurodegeneration after Cardiac Arrest
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • LRP1 and RAGE Genes Transporting Amyloid and Tau Protein in the Hippocampal CA3 Area in an Ischemic Model of Alzheimer’s Disease with 2-Year Survival
    • Year: 2023
    • Journal: Cells
  • The Dual Role of Autophagy in Postischemic Brain Neurodegeneration of Alzheimer’s Disease Proteinopathy
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Preservation of Biomarkers Associated with Alzheimer’s Disease (Amyloid Peptides 1-38, 1-40, 1-42, Tau Protein, Beclin 1) in the Blood of Neonates after Perinatal Asphyxia
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer’s Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids
    • Year: 2023
    • Journal: Molecules
  • Post-Ischemic Permeability of the Blood–Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimer’s Disease-Type Brain Neurodegeneration
    • Year: 2023
    • Journal: International Journal of Molecular Sciences

Dr Alexandros Kanellopoulos | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr Alexandros Kanellopoulos Neuroscience | Best ResearcherAward  🏆

Principal Scientist of Cognitive Health at DSM-Firmenich, RD Innovation
Switzerland🎓

Alexandros Kanellopoulos is a seasoned Innovation Leader, Principal Scientist, and Clinical Director with over 20 years of expertise in Neuroscience, Metabolism, Early Life Nutrition (ELN), and Medical Nutrition. He has successfully led multidisciplinary teams, pioneered product innovations, and authored more than 20 high-impact publications. With 7 patents to his name, Alexandros excels in transforming scientific research into tangible solutions that meet market needs.

Professional Profile 

Education

Alexandros Kanellopoulos holds a Ph.D. in Neuroscience from Kapodistrian University, Greece (2008-2013), where his research focused on neurodevelopmental disorders. Prior to this, he completed his M.Sc. in Molecular Medicine (Neuroscience) at the same university (2005-2007), gaining advanced expertise in neuroscience and molecular biology. His academic foundation was established with a B.Sc. in Molecular Biology and Genetics from Dimocritus University of Thrace, Greece (2000-2005), where he developed a strong background in genetics and molecular biology.

Work Experience

In his current role as Global Principal Scientist & Clinical Director at DSM-Firmenich (2023-Present), Alexandros oversees scientific activities, driving innovation in dietary supplements and medical nutrition. Prior to this, he worked as an R&D Innovation Scientist and Project Manager at Nestle SA (2022-2023), leading the development of brain health products for Early Life Nutrition. In 2023, he also held the position of Medical, Scientific & Regulatory Affairs Manager at Nestle Nutrition, focusing on market communication and regulatory compliance. Alexandros previously served as Group Leader, Early Life Brain Metabolism at the University of Lausanne (2020-2022) and as Senior Scientist in Early Life Neuroscience (2016-2020), where he pioneered research in neurodevelopmental disorders.

Skills 

Alexandros is highly skilled in Innovation & Product Development, leading projects from concept to market. He is an expert in Clinical Research & Protocol Design, managing complex preclinical and clinical trials. His ability to lead multidisciplinary teams and drive Cross-functional Collaboration is complemented by his talent for Stakeholder Engagement & Market Alignment, ensuring alignment between research innovations and market needs. His Strategic Thinking, Problem-solving, and Emotional Intelligence are key to his success in high-impact research and business projects.

Awards & Honors

Throughout his career, Alexandros has earned more than 15 research awards, securing CHF 2.5 million in research funding. He has been awarded 7 patents as an inventor, reflecting his contributions to innovation in neuroscience and nutrition. In addition, he has delivered over 40 invited presentations at international conferences, establishing himself as a respected thought leader in his field.

 Membership 

Alexandros contributes to the scientific community as a Reviewer for leading neuroscience journals and serves as an Editor in scientific publications, ensuring the dissemination of high-quality research.

Teaching Experience

Alexandros is also an experienced educator, having delivered lectures in Neuroscience and Medical Sciences at the University of Lausanne and Kapodistrian University, Athens. In his academic roles, he has mentored over 20 junior scientists, fostering the next generation of researchers and innovators.

Research Focus

Alexandros’ research centers on Early Life Nutrition and its role in brain development. He is particularly focused on Neurodevelopmental Disorders such as Autism and Fragile X Syndrome. His work on Brain Energy Metabolism and Mitochondrial Function provides insights into neurotransmission and social behavior. Alexandros has also designed Preclinical and Clinical Research aimed at developing nutritional solutions to address these complex medical challenges.

Publications : 

  • Activation of the 5-HT1A Receptor by Eltoprazine Restores Mitochondrial and Motor Deficits in a Drosophila Model of Fragile X Syndrome
    🧠 International Journal of Molecular Sciences – 2024
    DOI: 10.3390/ijms25168787
  • Aralar Sequesters GABA into Hyperactive Mitochondria, Causing Social Behavior Deficits
    🧬 Cell – 2020
    DOI: 10.1016/j.cell.2020.02.044
  • Conserved Tao Kinase Activity Regulates Dendritic Arborization, Cytoskeletal Dynamics, and Sensory Function in Drosophila
    🔬 The Journal of Neuroscience – 2020
    DOI: 10.1523/jneurosci.1846-19.2020
  • Domain-Specific Cognitive Impairments in Humans and Flies With Reduced CYFIP1 Dosage
    🧩 Biological Psychiatry – 2019
    DOI: 10.1016/j.biopsych.2019.04.008
  • SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse
    🧠 Neuron – 2019
    DOI: 10.1016/j.neuron.2019.05.002
  • Mitochondrial Dysfunction in Autism Spectrum Disorder: Clinical Features and Perspectives
    🧠 Current Opinion in Neurobiology – 2017
    DOI: 10.1016/j.conb.2017.05.018
  • Autism Spectrum Disorders: Translating Human Deficits into Mouse Behavior
    🐁 Neurobiology of Learning and Memory – 2015
    DOI: 10.1016/j.nlm.2015.07.013
  • Learning and Behavioral Deficits Associated with the Absence of the Fragile X Mental Retardation Protein: What a Fly and Mouse Model Can Teach Us
    🧠 Learning & Memory (Cold Spring Harbor, N.Y.) – 2014
    DOI: 10.1101/lm.035956.114
  • Learning and Memory Deficits Resulting from Reduction of the Fragile X Mental Retardation Protein: A Metabotropic Glutamate Receptor-Mediated Inhibition of cAMP Signaling in Drosophila
    🧠 The Journal of Neuroscience – 2012
    DOI: 10.1523/JNEUROSCI.1347-12.2012
  • Selective Serotonin Reuptake Inhibitors for the Treatment of Hypersensitive Esophagus: A Randomized, Double-blind, Placebo-controlled Study
    💊 The American Journal of Gastroenterology – 2011
    DOI: 10.1038/ajg.2011.179